Moreover, the expression of IL-6, TNF, and SOCS3 (suppressor of cytokine signaling 3) have been altered in a positive way to improve the quality of the postoperational life in CRC patients [70]. The gene discussed is SOCS3; the disease is colorectal carcinoma.